{{Rsnum
|rsid=1461567
|Gene=IRAK4
|Chromosome=12
|position=43770886
|Orientation=minus
|GMAF=0.2645
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IRAK4
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 47.8 | 44.2 | 8.0
| HCB | 23.4 | 57.7 | 19.0
| JPT | 16.8 | 50.4 | 32.7
| YRI | 98.4 | 0.0 | 1.6
| ASW | 84.2 | 15.8 | 0.0
| CHB | 23.4 | 57.7 | 19.0
| CHD | 37.6 | 43.1 | 19.3
| GIH | 30.7 | 50.5 | 18.8
| LWK | 0.0 | 0.0 | 0.0
| MEX | 65.5 | 27.6 | 6.9
| MKK | 98.7 | 1.3 | 0.0
| TSI | 53.5 | 42.6 | 4.0
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19254290
|Title=Polymorphisms in interleukin-1 receptor-associated kinase 4 are associated with total serum IgE
}}

{{PMID Auto
|PMID=23027530
|Title=Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}